Norway · Delayed Price · Currency is NOK Lifecare ASA Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 marked a transformative quarter with key milestones in implant validation, regulatory progress, and operational restructuring. Significant cost reductions and capital raises improved financial stability, while the focus shifts to regulatory execution and scaling production.
Fiscal Year 2025
-
Q4 2025 marked a shift from technology validation to operational execution, with regulatory milestones achieved and manufacturing reproducibility confirmed. Financially, short-term funding is secured, but future progress depends on warrant uptake and additional capital.
-
Secured $80 million in funding and finalized product design, with a veterinary market launch targeted for early 2026 and a human CE mark and European launch expected in 2027. Q3 saw high operating expenses due to intensive product development and regulatory preparations.
-
Development of implantable CGMs advanced with design freeze, clinical trial prep, and strategic partnerships. Q2 saw stable expenses, NOK 32M cash, and NOK 16M raised. Human and veterinary launches targeted for 2027 and 2025, with additional financing planned.
-
Advanced toward commercialization with design freeze and manufacturability milestones, improved sensor chemistry, and a dual focus on human and veterinary markets. Q1 saw NOK 25M in operating expenses and a NOK 25M loss, with funding runway into 2026. Market outlook remains strong amid rapid CGM segment growth.
Fiscal Year 2024
-
Listed on Euronext Oslo Børs, advanced sensor development, and improved glucose sensitivity mark Q4 2024. Operating expenses peaked due to R&D, but are expected to decline in 2025. CE mark for human use targeted for 2026–2027, with veterinary market entry planned for 2024.
-
Uplisting, automation advances, and a successful dog study marked the quarter, while the veterinary product launch was postponed to 2025 to ensure quality. Financials were stable, and strategic partnerships and acquisitions strengthened the foundation for future growth.